Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
13vPnC in healthy infants
NCT00205803Phase 2Completed
- Sponsor
- Pfizer
- Start
- Sep 2004
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of pneumococcal 13-valent conjugate vaccine in pneumococcal infection, sponsored by Pfizer. Started Sep 2004; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT00205803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00205803.